Prudential Financial’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
Other funds holding KIN
PWAM
AI
GIM
Prudential Financial's KIN Position: Q4 2020 in Review
Prudential Financial sold out of Kindred Biosciences, Inc. (KIN) in Q4 2020, closing a stake of 28,940 shares — an estimated $124K sold.
Prudential Financial first reported a position in KIN in Q1 2016 and held it in 16 quarters. The position peaked at $903K in Q3 2018. 82 funds tracked by Wall St. Rank hold KIN as of Q4 2020.
- Prudential Financial reported no remaining Kindred Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
- Prudential Financial sold 28,940 Kindred Biosciences, Inc. shares in Q4 2020, an estimated $124K.
- Prudential Financial first reported a position in Kindred Biosciences, Inc. in Q1 2016 and held it in 16 quarters.
- Prudential Financial's Kindred Biosciences, Inc. position peaked at $903K in Q3 2018.
- 82 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2020.
Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.